Extracellular signal-regulated kinase activates topoisomerase IIalpha through a mechanism independent of phosphorylation.
about
The SET and transposase domain protein Metnase enhances chromosome decatenation: regulation by automethylationPI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasmsExtracellular matrix as target for antitumor therapyA conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmissionExtracellular signal-regulated kinase 1/2 activity is not required in mammalian cells during late G2 for timely entry into or exit from mitosisMitogen-activated protein kinase kinase 1-dependent Golgi unlinking occurs in G2 phase and promotes the G2/M cell cycle transition.Growth arrest signaling of the Raf/MEK/ERK pathway in cancer.ERK2 enters the nucleus by a carrier-independent mechanismQuantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinity.Signal transduction by MAP kinases: regulation by phosphorylation-dependent switches.Changes in protein conformational mobility upon activation of extracellular regulated protein kinase-2 as detected by hydrogen exchange.Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cellsRas-MAP kinase signaling pathways and control of cell proliferation: relevance to cancer therapy.Abrogated thioredoxin system causes increased sensitivity to TNF-α-induced apoptosis via enrichment of p-ERK 1/2 in the nucleus.Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphomaAll tangled up: how cells direct, manage and exploit topoisomerase function.Topoisomerase IIα in chromosome instability and personalized cancer therapy.Characterization of ATP-independent ERK inhibitors identified through in silico analysis of the active ERK2 structureInhibiting MAP kinase activity prevents calcium transients and mitosis entry in early sea urchin embryosEpstein-Barr virus BGLF4 kinase induces premature chromosome condensation through activation of condensin and topoisomerase II.Structural Basis for the Non-catalytic Functions of Protein Kinases.Targeting prostate cancer based on signal transduction and cell cycle pathways.Working without kinase activity: phosphotransfer-independent functions of extracellular signal-regulated kinases.The secret life of kinases: functions beyond catalysisControl of gp130 expression by the mitogen-activated protein kinase ERK2.Ataxia telangiectasia mutated-dependent regulation of topoisomerase II alpha expression and sensitivity to topoisomerase II inhibitor.Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells.Neoamphimedine circumvents metnase-enhanced DNA topoisomerase IIα activity through ATP-competitive inhibitionNoncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling.Phosphorylation regulates nucleophosmin targeting to the centrosome during mitosis as detected by cross-reactive phosphorylation-specific MKK1/MKK2 antibodies.Regulation of Catalytic and Non-catalytic Functions of the Drosophila Ste20 Kinase Slik by Activation Segment PhosphorylationTyrosine-phosphorylated extracellular signal--regulated kinase associates with the Golgi complex during G2/M phase of the cell cycle: evidence for regulation of Golgi structureInvolvement of the MAP kinase ERK2 in MUC1 mucin signaling.ERK1/2 MAP kinases promote cell cycle entry by rapid, kinase-independent disruption of retinoblastoma-lamin A complexes.MAPK mediates RAS-induced chromosome instability.Overexpression of the atypical protein kinase C zeta reduces topoisomerase II catalytic activity, cleavable complexes formation, and drug-induced cytotoxicity in monocytic U937 leukemia cells.The interaction of Bex and OMP reveals a dimer of OMP with a short half-life.DNA topoisomerase II is required for the G0-to-S phase transition in Drosophila Schneider cells, but not in yeast.Expression of Topoisomerase II-α protein in salivary gland tumors.A cellular threshold for active ERK1/2 levels determines Raf/MEK/ERK-mediated growth arrest versus death responses.
P2860
Q24312178-253B14DE-5CF8-4691-A81E-384DF2B8D454Q26862544-D4D59299-A8D1-4B60-9D5F-4042BCDB83D0Q28082018-7029C80C-AF0D-45B1-BB8C-73560103F3EAQ28345384-7AFC82A3-7E2C-448F-ABE8-81DFE0FFDE26Q30478410-2AD141A5-023E-49EB-85BF-F3F0494CC06CQ30478912-829F4955-E1EF-4690-922D-EB2052D81C4DQ33836237-A399DA46-4389-4177-8F23-E9D6C466A8AEQ34064164-993B8DC9-5F6A-4FDD-9128-54612E676E30Q34509259-17884E05-9732-4553-82B1-CB14AEB0C984Q34543705-BFF702D3-0D61-466D-9619-EFEBD5517EE4Q34634651-BEA995E5-65F2-493D-B23C-7833B82EBF1EQ34681633-AC470F4C-3DC1-48DA-9FCA-ED12D78B4F70Q34973413-60CF53D5-5EC5-4454-B3F2-BD672EC333CBQ34988186-22546914-9CBB-4AFF-B491-4441F2F953FDQ35130674-C91C0D3C-0A6F-41C5-9924-16F6C4FA69B7Q35154537-7270B4EE-4E9D-4F49-BF8E-F44605783FDFQ35498796-6ADD897C-D65A-4454-9622-9A53ED12DD83Q35762145-AE427585-EFDB-4922-8131-02D701F252B4Q35799739-B463FD3E-80B7-42CA-8AFA-64816AC05F4BQ35857467-53F7CF77-3FB8-4416-A317-ECF73AB668B3Q36446161-3B330EB6-2A77-4FB0-82D7-11133AA36EBFQ36995054-2833606C-FC04-4B01-9E24-349696CBD6DEQ37949574-1721E0D5-4FA3-495C-B228-81CB09D287D8Q39077751-EBC78211-9A1F-44E6-80E3-49D1C41DBB99Q39149971-6C2E6DE4-EF8C-472E-AE72-DED17FE6F9E6Q39242603-E8BA7B18-3423-427D-A12E-86211D2A63F4Q39474160-0BB3883F-6E0A-4A45-BA8D-88323A6FCFE8Q39552095-5E301DF4-6AD5-4BAB-9F4D-0DA623BB4481Q39791081-BBB234E8-ABE3-4931-8D08-A6C864146101Q40608463-9FFD127A-7444-41EC-B7AC-CDD93A5544C7Q40741913-40B0E4D1-28B9-4E56-B54F-371294A9F865Q40796442-E7D3F14F-E92D-480E-AEC4-480ACFFC4776Q40798915-C06589D2-F21A-427C-92BF-118BC1F3A0F0Q41348151-30CD6111-1BA1-4D27-91E4-0346CD66ED77Q42807220-D324F096-5467-4FF5-80BE-77EF8EC121AFQ44053798-F36297CF-F7C4-4D5B-B24B-6F800DB0A848Q44937835-F43EFB26-39F4-4723-8F39-742370237489Q45088261-CF87B260-2577-4301-B8C2-C34E50AD9E6AQ47147047-B323EF64-7DC0-458C-A00E-BFE80EF285EDQ47848122-7C2A19CE-6C38-44E3-A848-390C5A0EFD5D
P2860
Extracellular signal-regulated kinase activates topoisomerase IIalpha through a mechanism independent of phosphorylation.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Extracellular signal-regulated ...... ndependent of phosphorylation.
@ast
Extracellular signal-regulated ...... ndependent of phosphorylation.
@en
type
label
Extracellular signal-regulated ...... ndependent of phosphorylation.
@ast
Extracellular signal-regulated ...... ndependent of phosphorylation.
@en
prefLabel
Extracellular signal-regulated ...... ndependent of phosphorylation.
@ast
Extracellular signal-regulated ...... ndependent of phosphorylation.
@en
P2093
P2860
P356
P1476
Extracellular signal-regulated ...... ndependent of phosphorylation.
@en
P2093
A M Whalen
J Wilsbacher
N Osheroff
N S Tolwinski
P S Shapiro
S J Froelich-Ammon
P2860
P304
P356
10.1128/MCB.19.5.3551
P407
P577
1999-05-01T00:00:00Z